• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染后有症状和无症状小鼠之间的比较揭示了新的炎症途径和相关微生物群。

Comparison between Symptomatic and Asymptomatic Mice after Infection Reveals Novel Inflammatory Pathways and Contributing Microbiota.

作者信息

AbdelKhalek Ahmed, Narayanan Sanjeev K

机构信息

Department of Comparative Pathobiology, Purdue University, 625 Harrison Street, West Lafayette, IN 47907, USA.

Purdue Institute of Inflammation, Immunology, and Infectious Disease, West Lafayette, IN 47907, USA.

出版信息

Microorganisms. 2022 Nov 30;10(12):2380. doi: 10.3390/microorganisms10122380.

DOI:10.3390/microorganisms10122380
PMID:36557633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9782979/
Abstract

causes the highest number of nosocomial infections. Currently, treatment options for infection (CDI) are very limited, resulting in poor treatment outcomes and high recurrence rates. Although the disease caused by CDI is inflammatory in nature, the role of inflammation in the development of CDI symptoms is contradictory and not completely understood. Hence, the use of anti-inflammatory medication is debatable in CDI. In the current study, we evaluated the genetic and microbiome profiles of mice after infection with . These mice were categorized based on the severity of CDI and the results were viewed accordingly. Our results indicate that certain genes are upregulated in severe CDI more than in the moderate case. These include oncostatin-M matrix metalloprotease 8 triggering receptor expressed on myeloid cells 1 ), and dual oxidase 2 . We also investigated the microbiome composition of CDI mice before and after infecting with . The results show that abundance is not indicative of diseases severity. Certain bacterial species (e.g., ) were enriched while others (e.g., ) were absent in severe CDI. This study identifies novel inflammatory pathways and bacterial species with a potential role in determining the severity of CDI.

摘要

导致医院感染数量最多。目前,艰难梭菌感染(CDI)的治疗选择非常有限,导致治疗效果不佳且复发率高。尽管CDI引起的疾病本质上是炎症性的,但炎症在CDI症状发展中的作用是矛盾的,尚未完全了解。因此,在CDI中使用抗炎药物存在争议。在当前的研究中,我们评估了感染[具体病原体未提及]后小鼠的基因和微生物组概况。这些小鼠根据CDI的严重程度进行分类,并相应地查看结果。我们的结果表明,某些基因在严重CDI中比在中度病例中上调得更多。这些基因包括抑瘤素-M、基质金属蛋白酶8、髓样细胞表达的触发受体1和双氧化酶2。我们还研究了感染[具体病原体未提及]前后CDI小鼠的微生物组组成。结果表明,[具体细菌未提及]的丰度并不表明疾病的严重程度。某些细菌物种(例如[具体细菌未提及])在严重CDI中富集,而其他一些细菌物种(例如[具体细菌未提及])则不存在。这项研究确定了在决定CDI严重程度方面具有潜在作用的新的炎症途径和细菌物种。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782e/9782979/a2593140611d/microorganisms-10-02380-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782e/9782979/a94dc42755ea/microorganisms-10-02380-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782e/9782979/b95819b84531/microorganisms-10-02380-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782e/9782979/dbfc7a45b93d/microorganisms-10-02380-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782e/9782979/6512734bcedc/microorganisms-10-02380-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782e/9782979/a2593140611d/microorganisms-10-02380-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782e/9782979/a94dc42755ea/microorganisms-10-02380-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782e/9782979/b95819b84531/microorganisms-10-02380-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782e/9782979/dbfc7a45b93d/microorganisms-10-02380-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782e/9782979/6512734bcedc/microorganisms-10-02380-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782e/9782979/a2593140611d/microorganisms-10-02380-g005.jpg

相似文献

1
Comparison between Symptomatic and Asymptomatic Mice after Infection Reveals Novel Inflammatory Pathways and Contributing Microbiota.感染后有症状和无症状小鼠之间的比较揭示了新的炎症途径和相关微生物群。
Microorganisms. 2022 Nov 30;10(12):2380. doi: 10.3390/microorganisms10122380.
2
The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity.肠道细菌群落增强艰难梭菌感染的严重程度。
mBio. 2022 Aug 30;13(4):e0118322. doi: 10.1128/mbio.01183-22. Epub 2022 Jul 20.
3
Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.肠道炎症和肠道微生物群改变与炎症性肠病相关,使小鼠易感染艰难梭菌定植和感染。
mBio. 2021 Jun 29;12(3):e0273320. doi: 10.1128/mBio.02733-20. Epub 2021 Jun 15.
4
Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.稀释粪菌移植可恢复抗生素扰乱的小鼠群落中艰难梭菌的定植抗性。
mBio. 2022 Aug 30;13(4):e0136422. doi: 10.1128/mbio.01364-22. Epub 2022 Aug 1.
5
S100B Inhibition Attenuates Intestinal Damage and Diarrhea Severity During Infection by Modulating Inflammatory Response.S100B 抑制通过调节炎症反应减轻 感染期间的肠道损伤和腹泻严重程度。
Front Cell Infect Microbiol. 2021 Sep 10;11:739874. doi: 10.3389/fcimb.2021.739874. eCollection 2021.
6
Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.系统炎症介质是预测艰难梭菌感染不良结局的有效生物标志物。
mBio. 2020 May 5;11(3):e00180-20. doi: 10.1128/mBio.00180-20.
7
Gut microbiome changes in mouse, Mongolian gerbil, and hamster models following challenge.小鼠、长爪沙鼠和仓鼠模型在受到攻击后肠道微生物群的变化。
Front Microbiol. 2024 Apr 4;15:1368194. doi: 10.3389/fmicb.2024.1368194. eCollection 2024.
8
Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.粪便微生物群移植治疗复发性肠道艰难梭菌感染 - 十年单中心经验。
Cas Lek Cesk. 2022 Summer;161(3-4):126-130.
9
Disordered Intestinal Microbial Communities During Colonization and Subsequent Infection of Hepatic Cirrhosis Patients in a Tertiary Care Hospital in China.中国一家三级医院中肝硬化患者定植和随后感染期间肠道微生物群落紊乱。
Front Cell Infect Microbiol. 2022 Apr 1;12:825189. doi: 10.3389/fcimb.2022.825189. eCollection 2022.
10
Integrated Meta-omics Reveals a Fungus-Associated Bacteriome and Distinct Functional Pathways in Clostridioides difficile Infection.整合宏基因组学揭示艰难梭菌感染中的真菌相关细菌组和独特的功能途径。
mSphere. 2019 Aug 28;4(4):e00454-19. doi: 10.1128/mSphere.00454-19.

引用本文的文献

1
Gut microbiome changes in mouse, Mongolian gerbil, and hamster models following challenge.小鼠、长爪沙鼠和仓鼠模型在受到攻击后肠道微生物群的变化。
Front Microbiol. 2024 Apr 4;15:1368194. doi: 10.3389/fmicb.2024.1368194. eCollection 2024.
2
Transplant of microbiota from Crohn's disease patients to germ-free mice results in colitis.将克罗恩病患者的微生物组移植到无菌小鼠中会导致结肠炎。
Gut Microbes. 2024 Jan-Dec;16(1):2333483. doi: 10.1080/19490976.2024.2333483. Epub 2024 Mar 27.

本文引用的文献

1
The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity.肠道细菌群落增强艰难梭菌感染的严重程度。
mBio. 2022 Aug 30;13(4):e0118322. doi: 10.1128/mbio.01183-22. Epub 2022 Jul 20.
2
Clostridioides difficile infection (CDI) during the COVID-19 pandemic.艰难梭菌感染(CDI)在 COVID-19 大流行期间。
Anaerobe. 2022 Apr;74:102518. doi: 10.1016/j.anaerobe.2022.102518. Epub 2022 Jan 19.
3
Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota.
艰难梭菌利用毒素介导的炎症来改变宿主的营养状况,并将肠道微生物群中的竞争者排除在外。
Nat Commun. 2021 Jan 19;12(1):462. doi: 10.1038/s41467-020-20746-4.
4
Quantitative characterization of Clostridioides difficile population in the gut microbiome of patients with C. difficile infection and their association with clinical factors.定量分析艰难梭菌感染患者肠道微生物组中艰难梭菌种群的特征及其与临床因素的关系。
Sci Rep. 2020 Oct 19;10(1):17608. doi: 10.1038/s41598-020-74090-0.
5
Repurposing the Veterinary Antiprotozoal Drug Ronidazole for the Treatment of Clostridioides difficile Infection.将兽医抗原生动物药物罗硝唑重新用于治疗艰难梭菌感染。
Int J Antimicrob Agents. 2020 Dec;56(6):106188. doi: 10.1016/j.ijantimicag.2020.106188. Epub 2020 Oct 9.
6
Severe colitis as potential late complication associated with COVID-19.严重结肠炎作为与COVID-19相关的潜在晚期并发症。
Ann R Coll Surg Engl. 2020 Sep;102(7):e176-e179. doi: 10.1308/rcsann.2020.0166. Epub 2020 Aug 17.
7
Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.2020 年 3 月-4 月,美国密歇根州底特律市,COVID-19 患者中的艰难梭菌。
Emerg Infect Dis. 2020 Sep;26(9):2272-4. doi: 10.3201/eid2609.202126. Epub 2020 May 22.
8
Metagenomic and culturomic analysis of gut microbiota dysbiosis during Clostridium difficile infection.艰难梭菌感染期间肠道微生物失调的宏基因组学和培养组学分析。
Sci Rep. 2019 Sep 5;9(1):12807. doi: 10.1038/s41598-019-49189-8.
9
Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate Colitis while Dysregulating the Inflammatory Response.非甾体抗炎药改变微生物群并加重结肠炎,同时使炎症反应失调。
mBio. 2019 Jan 8;10(1):e02282-18. doi: 10.1128/mBio.02282-18.
10
Indomethacin increases severity of Clostridium difficile infection in mouse model.吲哚美辛会增加艰难梭菌感染小鼠模型的严重程度。
Future Microbiol. 2018 Sep;13(11):1271-1281. doi: 10.2217/fmb-2017-0311. Epub 2018 Sep 21.